Nature Communications (May 2018)

Contrast-enhanced ultrasound measurement of pancreatic blood flow dynamics predicts type 1 diabetes progression in preclinical models

  • Joshua R. St Clair,
  • David Ramirez,
  • Samantha Passman,
  • Richard K. P. Benninger

DOI
https://doi.org/10.1038/s41467-018-03953-y
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 12

Abstract

Read online

Non-invasive techniques to assess the progression of type 1 diabetes prior to clinical onset are needed. Here the authors apply a contrast-enhanced ultrasound measurement of mouse pancreatic blood flow to detect changes in the islet microvasculature that undergoes rearrangements during diabetes and predict disease progression.